These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 24826818

  • 1. Novel N-substituted sophoridinol derivatives as anticancer agents.
    Bi CW, Zhang CX, Li YH, Tang S, Deng HB, Zhao WL, Wang Z, Shao RG, Song DQ.
    Eur J Med Chem; 2014 Jun 23; 81():95-105. PubMed ID: 24826818
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.
    Li X, Zhao WL, Jiang JD, Ren KH, Du NN, Li YB, Wang YX, Bi CW, Shao RG, Song DQ.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5251-4. PubMed ID: 21807514
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
    Cheng P, Zhu L, Guo W, Liu W, Yao J, Dong G, Zhang Y, Zhuang C, Sheng C, Miao Z, Zhang W.
    J Enzyme Inhib Med Chem; 2012 Jun 15; 27(3):437-42. PubMed ID: 21770860
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling.
    Le TN, Yang SH, Khadka DB, Van HT, Cho SH, Kwon Y, Lee ES, Lee KT, Cho WJ.
    Bioorg Med Chem; 2011 Jul 15; 19(14):4399-404. PubMed ID: 21684168
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
    Zhang X, Wang R, Zhao L, Lu N, Wang J, You Q, Li Z, Guo Q.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):1276-81. PubMed ID: 22079759
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT, Woo H, Jeong HM, Khadka DB, Yang SH, Zhao C, Jin Y, Lee ES, Youl Lee K, Kwon Y, Cho WJ.
    Eur J Med Chem; 2014 Jul 23; 82():181-94. PubMed ID: 24904965
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents.
    Li DD, Dai LL, Zhang N, Tao ZW.
    Bioorg Med Chem Lett; 2015 Oct 01; 25(19):4092-6. PubMed ID: 26299348
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
    Deane FM, O'Sullivan EC, Maguire AR, Gilbert J, Sakoff JA, McCluskey A, McCarthy FO.
    Org Biomol Chem; 2013 Feb 28; 11(8):1334-44. PubMed ID: 23314103
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity.
    Alonso C, Fuertes M, González M, Rubiales G, Tesauro C, Knudsen BR, Palacios F.
    Eur J Med Chem; 2016 Jun 10; 115():179-90. PubMed ID: 27017547
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.
    Zhou Y, Xu X, Sun Y, Wang H, Sun H, You Q.
    Bioorg Med Chem Lett; 2013 May 15; 23(10):2974-8. PubMed ID: 23566520
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo.
    Wang XM, Xin MH, Xu J, Kang BR, Li Y, Lu SM, Zhang SQ.
    Eur J Med Chem; 2015 May 15; 96():382-95. PubMed ID: 25911625
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
    Baechler SA, Fehr M, Habermeyer M, Hofmann A, Merz KH, Fiebig HH, Marko D, Eisenbrand G.
    Bioorg Med Chem; 2013 Feb 01; 21(3):814-23. PubMed ID: 23266176
    [Abstract] [Full Text] [Related]

  • 18. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
    Huang WY, Zhang XR, Lyu L, Wang SQ, Zhang XT.
    Bioorg Chem; 2020 Jun 01; 99():103814. PubMed ID: 32278208
    [Abstract] [Full Text] [Related]

  • 19. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
    Tabassum S, Zaki M, Afzal M, Arjmand F.
    Dalton Trans; 2013 Jul 21; 42(27):10029-41. PubMed ID: 23715526
    [Abstract] [Full Text] [Related]

  • 20. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
    Ismail MA, Tratrat C, Haroun MG.
    J Enzyme Inhib Med Chem; 2013 Dec 21; 28(6):1331-45. PubMed ID: 22957723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.